Viatris VTRS
NASDAQ VTRS
$16.11 -0.14 (-0.83%)
At close: Aug 20, 2026 · 1:50 PM UTC

Viatris (VTRS) Notes Payables (2020 - 2023)

Viatris (VTRS) posted quarterly Notes Payables of $100000.0 for Q3 2023, down 99.98% year-over-year from $500.4 million in Q3 2022, and down 99.57% quarter-over-quarter from $23.2 million in Q2 2023.

Viatris (VTRS) Notes Payables (2020 - 2023) Analysis & Trends

Viatris' Notes Payables history runs 4 years deep, the most recent figure standing at $100000.0 for Q3 2023.

  • In Q3 2023, Notes Payables fell 99.98% year-over-year to $100000.0; the TTM figure through Sep 2023 stood at $100000.0 (down 99.98% YoY), while the FY2021 annual figure was $1.5 billion, up 35.34% from the prior year.
  • Notes Payables for Q3 2023 stood at $100000.0, down from $23.2 million in the prior quarter.
  • The five-year high for Notes Payables was $1.7 billion in Q3 2021, with the low at $100000.0 in Q3 2023.
  • The 4-year median for Notes Payables is $655.4 million (2022), against an average of $730.8 million.
  • The sharpest annual moves came in 2022 and 2023: Notes Payables surged 1676.15% in 2022, then sank 99.98% in 2023.
  • Viatris' Notes Payables stood at $1.1 billion in 2020, then surged by 35.34% to $1.5 billion in 2021, then plunged by 66.42% to $500.4 million in 2022, then tumbled by 99.98% to $100000.0 in 2023.
  • Business Quant data shows VTRS's Notes Payables at $100000.0 in Q3 2023, $23.2 million in Q2 2023, and $204.6 million in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.89 Bn 42.93 Bn -
2 Teva Pharmaceutical Industries 43.01 Bn 39.35 Bn 2.15 Bn
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.17 Bn 19.51 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.85 Bn 1.46 Bn
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn -
10 Alkermes 8.12 Bn 7.46 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 100,000.00
Jun 30, 2023 23.20 Mn
Mar 31, 2023 204.60 Mn
Sep 30, 2022 500.40 Mn
Jun 30, 2022 1.02 Bn
Mar 31, 2022 655.40 Mn
Dec 31, 2021 1.49 Bn
Sep 30, 2021 1.71 Bn
Jun 30, 2021 1.30 Bn
Mar 31, 2021 36.90 Mn
Dec 31, 2020 1.10 Bn